Please wait

 

Exhibit 107

 

CALCULATION OF FILING FEE TABLES

 

Form S-3

(Form Type)

 

Marker Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security Type   Security
Class
Title		   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price
per Unit		   Maximum
Aggregate
Offering
Price		   Fee Rate   Amount of
Registration
Fee		   Carry
Forward
Form
Type		   Carry
Forward
File
Number		   Carry
Forward
Initial
Effective
Date		   Filing Fee
Previously
Paid in
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         
Fees to Be Paid   Equity   Common Stock,
par value
$0.001 per
share		   457(c)   10,062,500 (1)(2)   $2.91 (3)   $29,281,875 (3)   $153.10
per $1,000,000		   $4,483.06                —
                         
                         
    Total Offering Amounts        $29,281,875   $153.10 per $1,000,000   $4,483.06                
                   
    Total Fee Previously Paid                —                
                   
    Total Fee Offsets                —                
                   
    Net Fee Due                $4,483.06                

 

 

 

 

Table 2: Fee Offset Claims and Sources

                                             
                       
    Registrant
or Filer
Name		   Form
or
Filing Type		   File Number   Initial
Filing
Date		   Filing
Date		   Fee
Offset
Claimed		   Security Type
Associated
with Fee
Offset
Claimed		   Security
Title
Associated
with Fee
Offset
Claimed		   Unsold
Securities
Associated
with Fee
Offset
Claimed		   Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		   Fee
Paid
with
Fee
Offset Source
 
Rule 457(p)
                       
Fee Offset
Claims		                                   N/A        
                       
                                             

 

  (1) The securities registered consists of (a) 1,783,805 shares of common stock, (b) 3,247,445 shares of common stock to be acquired upon the exercise of Pre-Funded Warrants, and (c) 5,031,250 shares of common stock to be acquired upon the exercise of Private Placement Warrants.  

 

  (2) The shares of common stock will be offered for resale by the selling stockholders pursuant to the prospectus contained herein. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions.  

 

  (3) Estimated pursuant to Rules 457(c) under the Securities Act, solely for the purposes of calculating the registration fee and based on the average of the high and low prices of the Registrant’s common stock as reported on The Nasdaq Capital Market on January 8, 2025, which date is within five business days prior to the filing of this Registration Statement.